Studying the metabolome of specific
gestational compartments is
of growing interest in the context of fetus developmental disorders.
However, the metabolomes of the placenta and amniotic fluid (AF) are
poorly characterized. Therefore, we present the validation of a fingerprinting
methodology. Using pregnant rats, we performed exhaustive and robust
extractions of metabolites in the AF and lipids and more polar metabolites
in the placenta. For the AF, we compared the extraction capabilities
of methanol (MeOH), acetonitrile (ACN), and a mixture of both. For
the placenta, we compared (i) the extraction capabilities of dichloromethane,
methyl t-butyl ether (MTBE), and butanol, along with
(ii) the impact of lyophilization of the placental tissue. Analyses
were performed on a C18 and hydrophilic interaction liquid chromatography
combined with high-resolution mass spectrometry. The efficiency and
the robustness of the extractions were compared based on the number
of the features or metabolites (for untargeted or targeted approach,
respectively), their mean total intensity, and their coefficient of
variation (% CV). The extraction capabilities of MeOH and ACN on the
AF metabolome were equivalent. Lyophilization also had no significant
impact and usefulness on the placental tissue metabolome profiling.
Considering the placental lipidome, MTBE extraction was more informative
because it allowed extraction of a slightly higher number of lipids,
in higher concentration. This proof-of-concept study assessing the
metabolomics and lipidomics of the AF and the placenta revealed changes
in both metabolisms, at two different stages of rat gestation, and
allowed a detailed prenatal metabolic fingerprinting.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.